NCT Number: NCT00033020
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.
Looking for future studies?
Notify MeKey information
Age range
18 year–99 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Aegis Medical Systems, Inc., Bakersfield, California, United States
About this study
The purpose of the proposed research is to implement and systematically evaluate, in community treatment settings, motivational incentive procedures that have been well researched and have proven efficacious in a variety of treatment research clinics. The study will determine if motivational incentives along with standard care therapy is more effective than standard therapy alone for the treatment of patients using cocaine or methamphetamine and entering a substance abuse treatment program.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Recent admission to an opioid substitution (methadone maintenance) CTP. Completed at least 4 weeks of maintenance at time of study entry
- Evidence of cocaine or methamphetamine use Minimum of one documented positive urine within 2 weeks of study entry. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment
Exclusion criteria
- Unable to give informed consent (fails simple consent quiz)
- Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous gambling problems?
Treatment and study plan
Primary outcomes
-
ASI
-
Opioid and cocaine use
-
AIDS risk behavior
Sponsors and collaborators
Lead sponsor
Johns Hopkins University
Other
Registry information
Official study title
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Important dates
- Study start
- 2001
- Primary completion
- 2003
- Study completion
- 2003
- First posted
- Apr 8, 2002
- Registry last updated
- Jan 12, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder
NCT05886582
Chemically-Induced Disorders, Mental Disorders
Richmond, Virginia, United States
View Trial DetailsAlliances to Disseminate Addiction Prevention and Treatment (ADAPT)
NCT04499079
Behavior, Chemically-Induced Disorders
Indianapolis, Indiana, United States
View Trial DetailsFeasibility and Effects of Activity Trackers Among Alcohol Users Receiving In-patient Treatment for Alcohol Use Disorder
NCT06629493
Alcohol Use Disorder (AUD), Alcohol-Related Disorders
Gijón, Principality of Asturias, Spain
View Trial DetailsGrowing Together: Women in Opioid Treatment and Their Infants
NCT03866694
Behavior, Chemically-Induced Disorders
Boston, Massachusetts, United States
View Trial Details